Search Within

Shanu Modi

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (56)
  2. Journal Article (44)
  3. Review (4)
Groups
  1. Breast Medicine Service (104)
  2. Department of Medicine (104)
  3. GSK Faculty (104)
  4. Solid Tumor Oncology Division (104)
  5. Survivorship Research (68)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (64)

More Groups

People
  1. Sarat Chandarlapaty (49)
  2. Clifford Hudis (46)
  3. Sujata Patil (32)
  4. Larry Norton (29)
  5. Komal Jhaveri (25)
  6. Chau Dang (22)

More People

Years
  1. 2024 (8)
  2. 2023 (5)
  3. 2022 (5)
  4. 2021 (6)
  5. 2020 (9)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Cancer Research (24)
  3. Clinical Cancer Research (6)
  4. Breast Cancer Research and Treatment (5)
  5. Annals of Oncology (4)
  6. Clinical Breast Cancer (4)

More Publications

Publishers
  1. American Association for Cancer Research (31)
  2. American Society of Clinical Oncology (30)
  3. Nature Publishing Group (9)
  4. Elsevier Inc. (6)
  5. Oxford University Press (6)
  6. Springer (6)

More Publishers

Results (104)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I dose escalating trial of KOS-953 (heat shock protein 90 inhibitor) and trastuzumab (T)
    Meeting Abstract

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Solit, D.; Bagatell, R.; Ma, W.; Wheler, J.; Cropp, G. F.; Rosen, N.; Johnson, R. G. Jr; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients (pts) with Her2-positive breast cancer: Preliminary results
    Meeting Abstract

    Modi, S.; Stopeck, A.; Linden, H. M.; Sugarman, S.; Ma, W.; Solit, D.; Rosen, N.; Kersey, K.; Johnson, R. G.; Hannah, A. L.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Phase I trial of KOS-953, a heat shock protein 90 inhibitor, and trastuzumab (T)
    Meeting Abstract

    Modi, S.; Stopeck, A.; Gordon, M. S.; Solit, D.; Ma, W.; Wheler, J.; Cropp, G.; Johnson, R. G.; Hannah, A. L.; Hudis, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Inhibitors of Hsp90 induce the degradation of HER2 and inhibit the growth of HER2-dependent breast tumors
    Meeting Abstract

    Solit, D. B.; Basso, A.; Smith-Jones, P.; Modi, S.; Norton, L.; Larson, S.; Neckers, L.; Scher, H.; Hudis, C.; Rosen, N.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save